New inhaled treatment tested in fight against ALS
Disease control
Not yet recruiting
This study is testing whether an inhaled medication called RNS60 can help slow the progression of ALS. It will involve 140 adults with early-stage ALS who will use a nebulizer to breathe in the treatment. Researchers will measure changes in physical function, breathing, quality o…
Phase: PHASE2 • Sponsor: Revalesio Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC